Table 1.
Characteristics of M. tuberculosis drug resistance to first line antituberculosis drugs.
| Number of drugs | Number of isolates | Resistance to antituberculosis drugs (no and %) | ||||
|---|---|---|---|---|---|---|
| INH | STM | RMP | PZA | EMB | ||
| 1 | 8 | 5 (23.8) | 3 (21.2) | — | — | — |
| 2 | 6 | 6 (28.5) | 2 (18.1) | 2 (20.0) | 1 (12.5) | 1 (11.1) |
| 3 | 5 | 5 (23.8) | 2 (18.1) | 3 (30.0) | 2 (25.0) | 3 (33.3) |
| 4 | 1 | 1 (4.7) | — | 1 (10.0) | 1 (12.5) | 1 (11.1) |
| 5 | 4 | 4 (19.0) | 4 (36.3) | 4 (40.0) | 4 (50.0) | 4 (44.1) |
| Global resistance | 24 | 21 (23.3) | 11 (12.2) | 10 (11.1) | 8 (8.8) | 9 (10.0) |
INH: Isoniazid, STM: Streptomycin, RMP: Rifampicin, PZA: Pyrazinamide, EMB: Ethambutol.